Cash-rich Emblaze eyeing investment opportunities
Cash continues to be king at Emblaze, the Israeli technology firm which is suing Apple for alleged patent infringements.
Cash continues to be king at Emblaze, the Israeli technology firm which is suing Apple for alleged patent infringements.
The £54m valued company, which produces software for the fast growing mobile phone sector, finished 2011 with cash and short term investment assets of $149m, up from $145m at the end of 2010.
The group is carefully managing its cash so as to take advantage of changing market conditions, and is currently evaluating a number of investment opportunities.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company said it also ploughing on with its legal proceeding against iPhone maker Apple, as it believes the US electronics titan has infringed Emblaze's livee streaming patent.
The group saw revenue in 2011 surge to $1.21m from $0.63m in 2010, and this fed through to profit from continued operations of $2.8m, compared to a loss the year before of $4.6m.
The share price rose 3p to 48p on the release of the figures.
jh
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Which UK region has the most in savings? Average savings by area
The amount people have in their savings differs from region to region in the UK. How does your nest egg compare to those living nearby?
-
Doug and Mary Perkins: Specsavers’ clear-sighted founders
Helped by the deregulation of the sector in the 1980s and brilliant advertising, Mary Perkins and her husband Doug have taken Specsavers to the top of the optometry market